Ingredion Incorporated Reports Third Quarter 2026 Results

Ingredion posts lower Q3 earnings and cuts 2026 outlook amid cost and demand pressures.

What the company is saying

Ingredion Incorporated (NYSE: INGR) reports third quarter 2026 results that fell short of expectations, citing Argo’s slower financial recovery, higher input costs, and softer consumer demand as key factors. Chairman, president, and CEO Jim Zallie frames the narrative around operational challenges, especially at the Argo facility, and emphasizes a shift toward cost discipline and volume growth. The company highlights continued net sales volume growth in Texture & Healthful Solutions, but acknowledges profit headwinds from higher tapioca and manufacturing costs. In Latin America, volume gains in Mexico and Brazil are offset by foreign exchange impacts from a stronger Mexican peso and business disruption from an August earthquake in Colombia. The announcement lowers full-year 2026 guidance for EPS and operating income, attributing the change to persistent cost inflation and weaker demand, particularly in the U.S./Canada segment. Management also spotlights ongoing integration planning for the pending Tate & Lyle acquisition, positioning it as a future growth driver. The tone is candid about current headwinds, with forward-looking statements focused on operational improvements and strategic investments.

What the data suggests

Third quarter 2026 reported diluted EPS was $2.23, down from $2.61 a year earlier, while adjusted diluted EPS fell to $2.28 from $2.75. Reported and adjusted operating income dropped to $201 million and $206 million, respectively, both down 21% year-over-year excluding FX impacts. Net sales declined 1% to $1,792 million, primarily due to the sale of the majority stake in the Pakistan business; excluding Pakistan, net sales rose 2%. Texture & Healthful Solutions saw net sales rise 1% to $610 million, but operating income fell $10 million to $95 million due to higher input costs. Food & Industrial Ingredients–LATAM posted a 7% net sales increase to $624 million, but segment operating income slipped $7 million to $109 million, with FX and earthquake impacts cited. Food & Industrial Ingredients–U.S./CAN operating income dropped $29 million to $52 million, reflecting higher Argo costs and volume declines. Total debt at September 30, 2026 was $1.8 billion, with cash and equivalents at $993 million. Capital expenditures reached $313 million year-to-date, with full-year capex expected at $450–$490 million. The company paid $53 million in Q3 dividends, raised its quarterly dividend to $0.83 per share, and repurchased $85 million of stock toward a $100 million annual target. Full-year 2026 guidance now calls for reported diluted EPS of $8.04–$8.49 and adjusted EPS of $9.25–$9.70, both lower than prior expectations, with operating income projected down low double digits and adjusted operating income down mid-teens. Cash from operations is expected at $650–$750 million for the year. The figures indicate broad-based margin and earnings pressure, with management’s explanations for declines supported by segment-level data.

Analysis

The announcement is measured in tone and provides a detailed, transparent account of both realised results and forward-looking guidance. The company discloses a year-over-year decline in key profitability metrics (EPS, operating income) and explicitly lowers its full-year outlook, citing operational and market headwinds. While there are forward-looking statements regarding the pending Tate & Lyle acquisition and future earnings, these are presented as ongoing processes rather than as imminent value drivers. Capital expenditures are significant ($313 million YTD, $450–$490 million full-year expected), but the benefits are not immediate, especially as the company is still in the integration planning phase for the acquisition. There is no evidence of narrative inflation or exaggerated claims; the language is factual and acknowledges challenges. The gap between narrative and evidence is minimal, with most claims either supported by disclosed figures or clearly identified as projections.

Risk flags

• ●Operational risk is elevated due to persistent high input and manufacturing costs, particularly at the Argo facility, which have not yet been mitigated despite stable production and rebuilt inventories. This has led to significant margin compression and lower operating income.
• ●Foreign exchange volatility, especially the strength of the Mexican peso, and external shocks such as the August earthquake in Colombia, have negatively impacted LATAM segment results and may continue to disrupt earnings.
• ●Demand risk is evident as consumer softness and lower food and beverage demand have contributed to volume and profit declines, especially in the U.S./Canada segment, with no clear sign of near-term recovery.
• ●Financial risk is present given the company’s high capital expenditures ($313 million YTD, $450–$490 million full-year expected) and substantial debt load ($1.8 billion), which could pressure cash flows if earnings do not recover as projected.
• ●Integration risk surrounds the pending Tate & Lyle acquisition, as the company is still in the planning phase with no disclosed milestones or synergy targets, leaving uncertainty about the timing and magnitude of future benefits.

Bottom line

Ingredion’s Q3 2026 results confirm a material year-over-year decline in profitability, with reported and adjusted EPS and operating income all down sharply. The company’s lowered full-year outlook reflects ongoing cost inflation, operational setbacks at Argo, and weak demand in key segments, particularly in the U.S. and Canada. While management is taking steps to control costs and invest in specialty platforms, the near-term outlook remains pressured, and the integration of Tate & Lyle is still in early planning with no immediate financial upside. High capital expenditures and a sizable debt position add to financial risk if earnings recovery continues to lag. Investors should focus on the company’s ability to stabilize margins, deliver on cost discipline, and provide concrete progress on the Tate & Lyle integration. The most important takeaway is that operational and market headwinds have not yet been resolved, and further downside to earnings is possible if current trends persist.

Announcement summary

(NYSE: INGR) Ingredion Incorporated reported third quarter 2026 results, with performance falling short of expectations due to Argo's slower financial recovery, higher input costs, and softer consumer demand. Production at Argo remained stable for a second consecutive quarter, and inventories are largely rebuilt, but high manufacturing costs and weak food and beverage demand impacted profitable volume growth. Texture & Healthful Solutions achieved net sales volume growth for the tenth consecutive quarter, driven by strong global demand for clean label products, though higher tapioca and manufacturing input costs negatively affected profit growth. In Food & Industrial Ingredients—LATAM, stronger volume from brewing and beverage customers in Mexico and Brazil was offset by foreign exchange impacts from a stronger Mexican peso and the August earthquake in Colombia. The company lowered its full-year outlook, primarily due to slower earnings recovery in Food & Industrial Ingredients—U.S./CAN, higher input costs, and softer demand. Third quarter reported diluted EPS was $2.23, down from $2.61 in the prior year, while adjusted diluted EPS was $2.28, down from $2.75. Third quarter reported and adjusted operating income were $201 million and $206 million, respectively, both down 21% year-over-year excluding FX impacts. Total Ingredion net sales for the third quarter were $1,792 million, down 1% from $1,816 million in the prior year, primarily reflecting the sale of the majority stake in the Pakistan business. Texture & Healthful Solutions third quarter net sales were $610 million, up 1%, with operating income of $95 million, down $10 million year-over-year. Food & Industrial Ingredients–LATAM third quarter net sales were $624 million, up 7%, with operating income of $109 million, down $7 million year-over-year. Food & Industrial Ingredients–U.S./CAN third quarter net sales were $504 million, down 1%, with operating income of $52 million, down $29 million year-over-year. All Other segment third quarter net sales were $54 million, down 55%, with an operating loss of $11 million, an increase of $7 million from the prior year. At September 30, 2026, total debt was $1.8 billion and cash, including short-term investments, was $993 million. Net adjusted financing costs were $10 million in third quarter 2026, compared to $7 million in third quarter 2025. The reported effective tax rate for the third quarter was 26.8%, and the adjusted effective tax rate was 26.4%. Capital expenditures totaled $313 million through September 30, 2026, partially offset by $36 million in proceeds from property sales. The company paid $53 million in dividends in the third quarter and declared a quarterly dividend increase to $0.83 per share, paid on October 20, 2026, marking the 12th consecutive year of dividend increases. Through September 30, the company repurchased $85 million of common stock and is on track to complete its $100 million full-year share repurchase target. For full-year 2026, reported diluted EPS is expected to be in the range of $8.04 to $8.49, and adjusted diluted EPS in the range of $9.25 to $9.70. Full-year 2026 net sales are expected to be flat, with reported operating income expected to be down low double digits and adjusted operating income down mid-teens. Texture & Healthful Solutions operating income is expected to be flat to up low single-digits, Food & Industrial Ingredients—LATAM operating income down mid-to-high single-digits, Food & Industrial Ingredients—U.S./CAN operating income down 35-40%, and All Other’s operating loss anticipated to be approximately $(15) million. Corporate costs for full-year 2026 are expected to be down mid-single digits. The company expects a reported effective tax rate of 27.9% to 28.9% and an adjusted effective tax rate of 26.5% to 27.5% for 2026. Cash from operations for the full year 2026 is expected to be in the range of $650 million to $750 million. Capital expenditures for the full year are expected to be approximately $450 to $490 million. The company is progressing integration planning for the pending acquisition of Tate & Lyle. A conference call hosted by Jim Zallie, chairman, president and CEO, and Diego Reynoso, executive vice president and CFO, will be held on November 5, 2026.

Disagree with this article?